3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Carcinoma, Non-Small-Cell Lung
2
Neoplasms, Second Primary
1
Leukemia, Myeloid, Chronic-Phase
1
Gastro Intestinal Stromal Tumor
1
Congenital Abnormalities
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Flow Cytometry
13
Gene Expression Profiling
11
Polymerase Chain Reaction
9
Psychiatric Rehabilitation
6
Microarray Analysis
5
DNA Methylation
5
Therapeutics
4
Immunologic Techniques
4
Amplified Fragment Length Polymorphism Analysis
4
Reverse Transcriptase Polymerase Chain Reaction
3
In Situ Hybridization, Fluorescence
3
Immunoenzyme Techniques
3
Cytogenetic Analysis
2
Blotting, Western
2
Base Sequence
2
apremilast
1
Whole Genome Sequencing
1
Watchful Waiting
1
Valganciclovir
1
Tyrosine Kinase Inhibitors
1
Tissue Banks
1
Radiography, Panoramic
1
Pharmacogenomic Testing
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mass Spectrometry
1
Influenza Vaccines
1
Immunosuppression Therapy
1
High-Energy Shock Waves
1
Health Services Needs and Demand
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Congenital Abnormalities
×
Tyrosine Kinase Inhibitors
×
Clear all
NCT04151342
2025-12-03
CARMA-BROS
University Health Network, Toronto
Recruiting
5,500 enrolled